CARL Stock Analysis: Buy, Sell, or Hold?
CARL - Carlsmed, Inc. Common Stock
$16.05
-0.45 (-2.73%)
▼
5d:
+12.08%
30d:
+45.91%
90d:
+26.88%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 05, 2026
0d
Get Alerted When CARL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: CARL is 10.0% above its trading range ($14.59). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: CARL is 10.0% above its trading range ($14.59). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: CARL is currently trading at $16.05, which is considered extended relative to its 30-day fair value range of $11.53 to $14.59.
Technical Outlook: Technically, CARL is in a uptrend. Immediate support is located at $13.30, while resistance sits at $17.23.
Market Sentiment: CARL scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $19.20 (+19.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CARL is in a uptrend. Immediate support is located at $13.30, while resistance sits at $17.23.
Market Sentiment: CARL scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $19.20 (+19.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$11.53 -
$14.59
Company Quality Score
40/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
13.2%
All Signals
- BEARISH: Price significantly overextended (+10.0% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($19.20)
- WARNING: Composite score 40/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$11.53 -
$14.59
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$13.30
Resistance Level
$17.23
Current Trend
Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-11.63
Wall Street Target
$19.20
(+19.6%)
Revenue Growth (YoY)
56.7%
Profit Margin
-57.4%
Share & Embed Analysis
Last updated: August 23, 2026 8:21 PM ET
Data refreshes hourly during market hours. Next update: 9:21 PM
Data refreshes hourly during market hours. Next update: 9:21 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CARL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 50 HOLD |
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$254 | 33 SELL |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 51 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 37 SELL |
|
BTSG
BrightSpring Health Serv… |
STRONG BUY
12 analysts |
$79 | 63 BUY |